共 40 条
[1]
AKLILLU E, 1995, UNPUB FREQUENT DISTR
[2]
DEBRISOQUINE OXIDATION POLYMORPHISM - PHENOTYPIC CONSEQUENCES OF A 3-BASE-PAIR DELETION IN EXON 5 OF THE CYP2D6 GENE
[J].
PHARMACOGENETICS,
1993, 3 (03)
:123-130
[3]
An efficient strategy for detection of known and new mutations of the CYP2D6 gene using single strand conformation polymorphism analysis
[J].
PHARMACOGENETICS,
1995, 5 (06)
:373-384
[7]
DAHL ML, 1995, J PHARMACOL EXP THER, V274, P516
[8]
GENETIC AND METABOLIC CRITERIA FOR THE ASSIGNMENT OF DEBRISOQUINE 4-HYDROXYLATION (CYTOCHROME-P4502D6) PHENOTYPES
[J].
PHARMACOGENETICS,
1991, 1 (01)
:33-41
[9]
DALY AK, 1995, HUM GENET, V95, P337
[10]
DALY AK, 1996, IN PRESS PHARMACOGEN, V6